- Home
- SLND vs PRQR Comparison
SLND vs PRQR Comparison
Compare SLND & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLND
- PRQR
- Stock Information
- Founded
- SLND 1900
- PRQR 2012
- Country
- SLND United States
- PRQR Netherlands
- Employees
- SLND N/A
- PRQR N/A
- Industry
- SLND Military/Government/Technical
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- SLND Industrials
- PRQR Health Care
- Exchange
- SLND Nasdaq
- PRQR Nasdaq
- Market Cap
- SLND 210.6M
- PRQR 250.7M
- IPO Year
- SLND N/A
- PRQR 2014
- Fundamental
- Price
- SLND $4.15
- PRQR $2.12
- Analyst Decision
- SLND Buy
- PRQR Strong Buy
- Analyst Count
- SLND 2
- PRQR 7
- Target Price
- SLND $4.50
- PRQR $8.14
- AVG Volume (30 Days)
- SLND 49.6K
- PRQR 448.1K
- Earning Date
- SLND 11-12-2025
- PRQR 11-06-2025
- Dividend Yield
- SLND N/A
- PRQR N/A
- EPS Growth
- SLND N/A
- PRQR N/A
- EPS
- SLND N/A
- PRQR N/A
- Revenue
- SLND $935,461,000.00
- PRQR $18,859,556.00
- Revenue This Year
- SLND N/A
- PRQR N/A
- Revenue Next Year
- SLND $3.50
- PRQR N/A
- P/E Ratio
- SLND N/A
- PRQR N/A
- Revenue Growth
- SLND N/A
- PRQR N/A
- 52 Week Low
- SLND $1.85
- PRQR $1.07
- 52 Week High
- SLND $5.34
- PRQR $4.21
- Technical
- Relative Strength Index (RSI)
- SLND 40.76
- PRQR 35.84
- Support Level
- SLND $4.40
- PRQR $1.97
- Resistance Level
- SLND $4.59
- PRQR $2.27
- Average True Range (ATR)
- SLND 0.31
- PRQR 0.20
- MACD
- SLND -0.01
- PRQR -0.08
- Stochastic Oscillator
- SLND 11.19
- PRQR 16.12
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.